$IMRX SEC Filings

Filed On	Filing
05 Aug 2026	10-Q
05 Aug 2026	8-K: Results of Operations and Financial Condition
28 Jul 2026	SCHEDULE 13G
17 Jul 2026	Form 4: Gengos Andrew, Chief Financial Officer Granted 650,000 Stock Option
16 Jul 2026	Form 3: Gengos Andrew, Chief Financial Officer Holds 225,000 shares of Class A Common Stock
24 Jun 2026	Form 4: Zeskind Benjamin J., Director Bought 2,400 shares ($10.9K)
16 Jun 2026	Form 4: Hall Brett Matthew, CHIEF SCIENTIFIC OFFICER Bought 6,035 shares ($25K)
15 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
11 Jun 2026	Form 4: Schall Thomas J., Director Granted 33,350 Stock Option
11 Jun 2026	Form 4: Hausman Diana, Director Granted 33,350 Stock Option
11 Jun 2026	Form 4: Carpenter Robert J, Director Granted 33,350 Stock Option
11 Jun 2026	Form 4: Keating Laurie, Director Granted 33,350 Stock Option
11 Jun 2026	Form 4: Feinberg Peter, Director Granted 33,350 Stock Option
11 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
01 Jun 2026	8-K: Other Events
15 May 2026	10-Q
15 May 2026	8-K: Results of Operations and Financial Condition
20 Apr 2026	DEFA14A
20 Apr 2026	DEF 14A
17 Mar 2026	Form 4: Neufeld Leah R, CHIEF PEOPLE OFFICER Received 3,628 shares as a grant or award ($15.6K)

Comments